Close Menu

In a news story, Brendan Maher reports on the focus on exome sequencing at the Cold Spring Harbor Biology of Genomes meeting. According to Maher, the International Cancer Genome Consortium will focus on sequencing exomes, or just the 1 percent of the genome that is known to code for proteins. However, some say that this could turn out to be a "piecemeal half-step, and not provide a full picture of the mutations that lead to cancer," he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.